 |
J P Morgan Healthcare Conference
9-11 January 06, San Francisco
|
TAT2006 (Targeted Anticancer Therapies)
16-18 March 2006, Amsterdam
www.nddo.org
The 4th International Symposium on Targeted Anticancer Therapies (TAT 2006) has demonstrated that this annual meeting series has come of age. It provides an excellent forum for the presentation and discussion of virtually all aspects of targeted anticancer therapies in (pre)clinical development. TAT 2006 was the second meeting in this series organized as a partnership meeting between the NDDO Research Foundation and ESMO |
BioCapital Europe
21 March 06, Amsterdam
www.biocapitaleurope.com
BioCapital Europe showcases the most promising investment opportunities in the biotech sector to an elite group of investors. The companies selected to present range from early stage to late stage investment opportunities. The conference centres around company presentations and allows investors to closely interact with various companies and their senior executives. Attendance by invitation only. |
AACR (American Association for Cancer Research)
1-5 April 06, Washington DC
www.aacr.org.com
The AACR Annual Meeting is the most important cancer research meeting in the world. Attendance is essential for all who are committed to learning about the latest discoveries and trends across the entire spectrum of cancer research. This year’s theme centered on new and promising therapeutic approaches and was reflected in the Opening Plenary Session titled “Looking into the Future of Cancer Therapy”. |
BIO2006 Chicago
10-12 April 06
www.bio.org/events/2006
BIO represents more than 1100 biotechnology companies, academic institutions, state biotechnology centers and related organisations across the US and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. |
BioWindhover
15-17 May 2006, Washington DC
www.biowindhover.com
Major networking event with approximately 400 senior decision makers attending from the R&D and business development:sector. The meeting provides pharmaceutical firms with a targeted group of companies that fill particular pipeline or technology needs, and also provide those select biotechs with an opportunity to meet face-to-face with senior pharmaceutical business and scientific management responsible for deal-making. |
BioEquity Europe
23 May 2006, Frankfurt
www.biocentury.com
The 7 th Anniversary Meeting supported by Nomura Phase4 Ventures which brings together professional investors, bankers and analysts with leading public and late stage private companies. |
42nd ASCO Annual Meeting (American Society of Clinical Oncology)
2-6 June 2006, Atlanta
www.asco.org
The ASCO Annual Meeting is considered the premier educational and scientific event in the oncology community. The 2005 Meeting in Orlando attracted more than 29,000 attendees from all over the world. |
Windhover - Therapeutic Oncology Alliances Conference
6-7 June 2006, Atlanta
www.oncologyalliances.com
Windhover's TA ONCOLOGY meeting brings research and business development together into a more productive initial meeting, focused on the researcher's area of interest and capitalises on potential new business and collaboration opportunities with the hottest oncology in-licensers and out-licensers. |
11th Congress of the Hematology Association
14-16 June 2006, Amsterdam
www. congress.ehaweb.org/11th
Expert hematologists presenting their timely views in sessions of a different scope covering both benign and malignant hematology. Delegates participate in high quality Education, Meet-the-Expert, Hematology-in-Focus and Plenary sessions, as well as in challenging Lunch Debates, Clinical Trial Updates and Science-in-Progress sessions. |
BioPharmaceutical Conference in Europe
14-16 June 2006, Lisbon
www.biopharmconference.com
This is an exclusive 'by invitation only' event, which provides a unique setting for like-minded individuals, at the most senior level to meet and explore new business opportunities in a relaxed, informal setting away from day to day business distractions. The programme offers formal keynote presentations as well as lively panel discussions. |
23rd Int. Conf. Advances in application of Monoclonal Antibodies in Clinical Oncology
26-28 June 2006, Mykonos, Greece
Speakers are renowned experts in their fields presenting the most recent and exciting work in the tumour targeting arena.
|
|
|
 |
 |
5th Annual EC21 BioVentures Conference
22-23 March 2005,
London
BioVenture Leadership Session: "Getting Bigger and Better – M&A Activity in Europe "
IJN joined a panel of experts to discuss the practical realities of M&A activity in Europe
www.techvision/com/ec21 |
SG Cowen & Co. 25th Annual Health Care Conference
14-17 March 2005,
Boston
Presentations from top management of over 250 high interest companies
www.sgcowen.com/PastConferences.asp |
BioCapital Europe - Fortis Bank Life Science Partners
1 March 2005,
Amsterdam
Life science companies from throughout Europe presented their latest innovations and developments.
www.biocapitaleurope.com |
Investing in European Biotechnology: Risks and Rewards
1 December 2004,
Madrid
Conference arranged by Gilde Investment Management in association with a Spanish Institution. Ian Nicholson presented on "The European Biotech SME Perspective" |
BioBusiness Network 2005
25-28 January 2005
President Wilson Hotel, Geneva
http://www.wbresearch.com/biobusinessnetwork |
The Third Swiss Re Private Equity Forum
15 September 2004
Centre for Global Dialogue, Rüschlikon, Switzerland
This half-day event and executive dinner, targeted a limited number of institutional investors and featured speakers from the entire private equity value chain (institutional investors, fund of funds managers, fund managers and portfolio companies). As well as gaining insight into the latest developments and prognoses, participants also had the chance to hear institutional investors’ views on how and why one should invest in private equity, and assess the contribution of each of the above mentioned players to the value chain. |
12th Annual Atlas Venture Life Sciences Conference
19-21 September 2004
Palais de la Méditerranée, Nice
http://www.atlasventure.com/LSC/content.asp?id=6 |
4th Annual Biotech in Europe Investor Forum
Organised by Sachs Associates in association with Bloomberg LP
5-6 October 2004
Swissôtel Zurich, Switzerland
http://www.sachsforum.com/zurich2004_fs.html |
|
|
|
|
|
